Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions ...

Biotech conglomerate Danaher Corp. faces a proposed class action and collective from White male workers fighting its hiring policy promoting diversity, equity, and inclusion.

The Boston Legacy FC soccer team, due to begin play next year in the women’s soccer league NWSL, has closed on over $100 ...

Three years on from a splashy unveiling, Areteia Therapeutics has reported a phase 3 victory that could boost its bid to launch an oral rival to the biologics that dominate a multibillion-dollar ...

White House plans potential restrictions on Chinese-developed drugs, sparking lobbying from investors and pharmaceutical giants amid national security concerns.

Looking for low-cost biotech opportunities with big upside? In this video, MarketBeat’s Chris Markoch breaks down 3 speculative biotech stocks trading under $5 — each with significant growth potential ...

The Trump administration is working on a draft executive order, which, if finalized, could impose harsh restrictions on drugs ...

The former chair of America’s Council of Economic Advisers wants NATO-style spending targets for innovative medicines ...

The Trump administration is considering putting “severe restrictions” on the increasing flow of investigational drugs from ...

In almost all solid tumors - i.e. cancers with a solid tissue structure - the detection of tumor cells in the lymph nodes is ...

Economically, INNOVERA positions tanners to better compete with synthetic materials. While much of the market is flooded with ...

Archer and Joby are racing toward FAA certification with billions in backing, strategic partnerships, and clear paths to commercial launch.